Author

Surendiran A

Associate Professor of Pharmacology, JIPMER - Cited by 1,198 - Pharmacogenomics

Biography

Dr. A. Surendiran is currently working as Assistant Professor in Department of Pharmacology, Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Puducherry, India. He completed his MBBS and MD Pharmacology courses from the same Institute in 2007 and 2010, respectively. His area of interest includes Pharmacogenetics, Molecular biology, Drug safety and Pharmacovigilance, Oncology, Diabetes Mellitus, Biostatistics and Medical Education. His worked on pharmacogenetics of glibenclamide in diabetes mellitus as his MD thesis.
Title
Cited by
Year
Novel applications of nanotechnology in medicine
A Surendiran, S Sandhiya, SC Pradhan, C AdithanIndian Journal of Medical Research 130 (6), 689-701, 2009200
267
2009
Emerging trends of nanomedicine–an overview
S Sandhiya, SA Dkhar, A SurendiranFundamental & clinical pharmacology 23 (3), 263-269, 2009200
198
2009
Effect of slow and fast pranayams on reaction time and cardiorespiratory variables
P Vijayalakshmi, A SurendiranIndian J Physiol Pharmacol 49 (3), 313-318, 2005200
170
2005
A study of adverse drug reactions in pediatric patients
R Priyadharsini, A Surendiran, C Adithan, S Sreenivasan, FK SahooJournal of Pharmacology and Pharmacotherapeutics 2 (4), 277-280, 2011201
112
2011
Adverse drug reaction profile of cisplatin-based chemotherapy regimen in a tertiary care hospital in India: An evaluative study
A Surendiran, N Balamurugan, K Gunaseelan, S Akhtar, KS Reddy, ...Indian journal of pharmacology 42 (1), 40, 2010201
85
2010
Influence of the CYP2CP & CYP2C19 polymorphisms on phenytoin hydroxylation in healthy individuals from south India
J Rosemary, A Surendiran, S Rajan, CH Shashindran, C AdithanIndian Journal of Medical Research 123 (5), 665, 2006200
63
2006
Influence of CYP2C9 gene polymorphisms on response to glibenclamide in type 2 diabetes mellitus patients
A Surendiran, SC Pradhan, A Agrawal, DKS Subrahmanyam, S Rajan, ...European journal of clinical pharmacology 67, 797-801, 2011201
61
2011
Role of pharmacogenomics in drug discovery and development
A Surendiran, SC Pradhan, C AdithanIndian journal of pharmacology (4), 137, 2008200
40
2008
Genetic polymorphisms of drug‐metabolizing phase I enzymes CYP2E1, CYP2A6 and CYP3A5 in South Indian population
D Krishnakumar, U Gurusamy, K Dhandapani, A Surendiran, R Baghel, ...Fundamental & clinical pharmacology 26 (2), 295-306, 2012201
35
2012
Serotonin transporter gene (SLC6A4) polymorphisms are associated with response to fluoxetine in south Indian major depressive disorder patients
SA Aarthi Manoharan, Deepak Gopal Shewade, Ravi Philip RajkumarEuropean Journal of Clinical Pharmacology, 2016201
27
2016
Role of CYP2C19 gene polymorphism in acute alcohol withdrawal treatment with loading dose of diazepam in a South Indian population
M Jose, J Mathaiyan, S Kattimani, S Adithan, A ChandrasekaranEuropean journal of clinical pharmacology 72, 807-812, 2016201
27
2016
Risperidone-induced adverse drug reactions and role of DRD2 (− 141 C Ins/Del) and 5HTR2C (− 759 C> T) genetic polymorphisms in patients with schizophrenia
CG Alladi, A Mohan, DG Shewade, RP Rajkumar, S Adithan, ...Journal of Pharmacology and Pharmacotherapeutics 8 (1), 28-32, 2017201
21
2017
Effect of Curcuma longa on vascular function in native Tamilians with type 2 diabetes mellitus: A randomized, double‐blind, parallel arm, placebo‐controlled trial
A Srinivasan, S Selvarajan, S Kamalanathan, T Kadhiravan, ...Phytotherapy Research 33 (7), 1898-1911, 191
20
2019
Genetic variation and haplotype structure of the gene Vitamin K epoxide reductase complex, subunit 1 in the Tamilian population
DK Kumar, DG Shewade, A Surendiran, C AdithanJournal of Pharmacology and Pharmacotherapeutics 4 (1), 53-58, 202
13
2013
Oncolytic virotherapy–A novel strategy for cancer therapy
MG Gopisankar, A SurendiranEgyptian Journal of Medical Human Genetics 19 (3), 165–169-165–169, 2018201
13
2018
Dopamine (DRD2) and Serotonin (HTR2A, 2C) Receptor Gene Polymorphisms do not influence early response to Risperidone in South Indian Patients with …
CG Alladi, RP RajKumar, S Adithan, C Marie‐Claire, F Bellivier, ...Fundamental & clinical pharmacology 33 (3), 355-364, 2019201
11
2019
Influence of cytochrome P450 3A5 (CYP3A5) genetic polymorphism on dose-adjusted plasma levels of carbamazepine in epileptic patients in South Indian population
M Ganesapandian, K Ramasamy, S Adithan, SK NarayanIndian Journal of Pharmacology 51 (6), 384, 2019201
10
2019
Azithromycin-induced hiccups
A Surendiran, DK Kumar, C AdithanJournal of Postgraduate Medicine 54 (4), 330, 2008200
9
2008
Resequencing CYP2D6 gene in Indian population: CYP2D6*41 identified as the major reduced function allele
A Manoharan, DG Shewade, PA Ravindranath, RP Rajkumar, ...Pharmacogenomics 20 (10), 719-729, 2019201
5
2019
Medication error–Inadvertent high dose intradermal cloxacillin induced skin necrosis
A Surendiran, MV Kaku, C AdithanIndian Journal of Pharmacology 44 (1), 122, 2012201
3
2012

Referred From: https://scholar.google.com/citations?user=WdlBktkAAAAJ&hl=en&oi=sra

Cited by
Citations 1198
h-index 13
i10-index 17
Recommended Journals
Open Access Journals